Stocks and InvestingStocks and Investing
Mon, November 11, 2019
Fri, November 8, 2019
Thu, November 7, 2019
Wed, November 6, 2019

Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $48 on, Nov 6th, 2019


Published on 2024-10-26 17:52:42 - WOPRAI, Matthew Mishan
  Print publication without navigation


Matthew Mishan of Keybanc, Maintained "Avanos Medical, Inc." (AVNS) at Buy with Decreased Target from $51 to $48 on, Nov 6th, 2019.

Matthew, nor any peers, have made any analyst calls on AVNS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30